Intensive glucose regulation decreases the risk of diabetic nephropathy and also suppresses the renin–angiotensin system (RAS) and is a significant treatment target both for the prevention and management of diabetic nephropathy [73]. This evidence concerns the gene REN and diabetic kidney disease.